Cite
Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs.
MLA
Brayton, Kimberly M., et al. “Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs.” PLoS ONE, vol. 9, no. 12, Dec. 2014, pp. 1–15. EBSCOhost, https://doi.org/10.1371/journal.pone.0114597.
APA
Brayton, K. M., Hirsch, A. T., O, B. P. J., Cheville, A., Karaca-Mandic, P., & Rockson, S. G. (2014). Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs. PLoS ONE, 9(12), 1–15. https://doi.org/10.1371/journal.pone.0114597
Chicago
Brayton, Kimberly M., Alan T. Hirsch, Brien, Patricia J. O, Andrea Cheville, Pinar Karaca-Mandic, and Stanley G. Rockson. 2014. “Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs.” PLoS ONE 9 (12): 1–15. doi:10.1371/journal.pone.0114597.